ICHNOS SCIENCES S A has a total of 29 patent applications. Its first patent ever was published in 2012. It filed its patents most often in Republic of Korea, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are DEV CENTER BIOTECHNOLOGY, BIOCAD JOINT STOCK CO and UCB Biopharma SRL.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 8 | |
#2 | WIPO (World Intellectual Property Organization) | 7 | |
#3 | Canada | 4 | |
#4 | Australia | 2 | |
#5 | Israel | 2 | |
#6 | Brazil | 1 | |
#7 | China | 1 | |
#8 | Colombia | 1 | |
#9 | EPO (European Patent Office) | 1 | |
#10 | Philippines | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement | |
#5 | Chemical engineering |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Heterocyclic compounds | |
#5 | Analysing materials | |
#6 | Special acyclic compounds | |
#7 | Measuring microorganism processes | |
#8 | Fermentation | |
#9 | Microorganisms | |
#10 | Separation |
# | Name | Total Patents |
---|---|---|
#1 | Gudi Girish | 8 |
#2 | Abrantes Filipa | 6 |
#3 | Sant Sumit | 5 |
#4 | Letestu Sonia | 5 |
#5 | Menon Vinu C A | 5 |
#6 | Tandon Monika | 5 |
#7 | Talluri Ravi | 5 |
#8 | Cahuzac Laure | 5 |
#9 | Duarte Lionel | 5 |
#10 | Khairatkar-Joshi Neelima | 4 |
Publication | Filing date | Title |
---|---|---|
WO2020126104A2 | Methods of cell culture clarification | |
WO2020070331A1 | Indolinone compounds for use as map4k1 inhibitors | |
WO2020064865A1 | Antibody quantification in biological samples | |
WO2020053301A1 | Compositions comprising a bispecific antibody, bufffer and one or more stabilizing agents | |
WO2020016417A1 | Liquid antibody formulation | |
WO2020011759A1 | Methods to determine the monoclonality of a cell population | |
EP3802600A1 | Anti-ox40 antagonistic antibodies and dosage for the treatment of ox40-mediated disorders |